KING KHALID NATIONAL GUARD HOSPITALPHARMACY AND THERAPEUTICS COMMITTEE

DRUG EVALUATION

GENERIC NAME OF THE DRUG: MEBO OINTMENTRequestor: Dr. Mansoor Ahmed Khan.

Clinical Pharmacist Adult Oncology / Hematology.Manufacturer: Julphar.

1. Trade Name:ß-sitosterol.

2. AHFS Pharmacology- Therapeutic Class: Tissue healing agent:1. Skin Regeneration.2. Analgesic Effects.3. Prevention and Control of Infection ( Antibiotic ).4. Anti-inflammatory Effects.

3. Related Agents Already on Formulary: Flamazine ( Silver Sulfadiazine )

4. FDA Approved Indications:1. First-degree burns, where the pain relief and the fast healing are remarkable, e.g. sunburn.2. Second degree burns, superficial and deep. If properly applied, no skin grafting is needed and regeneration takes place from hair follicles and glands in the dermisand subcutaneous tissue.3. Third degree burns, to isolate the wound, reduce pain, and expedite nonsurgical debridement of the necrotic tissue to prepare the wound for grafting.

5. Registered in the Kingdom: Yes No

6. Rationale for Formulary Addition:

6.1 Physician’s (Requestor’s) perspective

6.2 Objective Literature Evaluation:

x